---
title: 'The role of host response to chemotherapy: resistance, metastasis and clinical
  implications'
date: '2023-11-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37999904/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231124170841&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Chemotherapy remains the primary treatment for most metastatic cancers.
  However, the response to chemotherapy and targeted agents is often transient, and
  concurrent development of resistance is the primary impediment to effective cancer
  therapy. Strategies to overcome resistance to treatment have focused on cancer cell
  intrinsic factors and the tumor microenvironment (TME). Recent evidence indicates
  that systemic chemotherapy has a significant impact on the host that either facilitates
  ...
disable_comments: true
---
Chemotherapy remains the primary treatment for most metastatic cancers. However, the response to chemotherapy and targeted agents is often transient, and concurrent development of resistance is the primary impediment to effective cancer therapy. Strategies to overcome resistance to treatment have focused on cancer cell intrinsic factors and the tumor microenvironment (TME). Recent evidence indicates that systemic chemotherapy has a significant impact on the host that either facilitates ...